Entrada Therapeutics logo

Entrada Therapeutics

TRDA | NASDAQ
Chart Builder DCF Calculator
$5.00
-$0.09 (-1.77%)
At close: Nov 16, 2026, 4:00 PM ET
$5.07
+$0.07 (+1.40%)
After-hours: Nov 16, 2026, 4:39 PM ET
-1.77%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
32.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #744/1021 (Top 73%)

Key Statistics

Market Data

Market Cap $211.87M
1D Range
4.84 5.22
52W Range
4.37 16.03

Valuation (TTM)

PE -1.30
PB 1.07
EV/EBITDA -0.41

Valuation (NTM)

Forward PE N/A
Forward PEG -0.16
Price Target $14.00
Loading financial charts...

Profile

Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailmen...

Sector Healthcare
Industry Biotechnology
Employees 152
IPO Date Oct 29, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.94
Beat +6.93%
REV
$905K
Miss -60.58%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$14.00
Upside
+180.00%
Buy (2)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.